SLC22A23

gene
On this page

Also known as FLJ22174

Summary

SLC22A23 (solute carrier family 22 member 23, HGNC:21106) is a protein-coding gene on chromosome 6p25.2, encoding Solute carrier family 22 member 23 (A1A5C7).

SLC22A23 belongs to a large family of transmembrane proteins that function as uniporters, symporters, and antiporters to transport organic ions across cell membranes (Jacobsson et al., 2007 [PubMed 17714910]).

Source: NCBI Gene 63027 — RefSeq curated summary.

At a glance

  • GWAS associations: 59
  • Clinical variants (ClinVar): 89 total
  • MANE Select transcript: NM_015482

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21106
Approved symbolSLC22A23
Namesolute carrier family 22 member 23
Location6p25.2
Locus typegene with protein product
StatusApproved
AliasesFLJ22174
Ensembl geneENSG00000137266
Ensembl biotypeprotein_coding
OMIM611697
Entrez63027

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 7 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000380298, ENST00000380302, ENST00000406686, ENST00000433689, ENST00000436008, ENST00000467144, ENST00000467177, ENST00000482874, ENST00000485307, ENST00000490273, ENST00000496753, ENST00000497691

RefSeq mRNA: 8 — MANE Select: NM_015482 NM_001286455, NM_001286456, NM_001382317, NM_001382318, NM_001382319, NM_001382321, NM_015482, NM_021945

CCDS: CCDS34331, CCDS47363, CCDS75389

Canonical transcript exons

ENST00000406686 — 10 exons

ExonStartEnd
ENSE0000194911532689733273412
ENSE0000347564032897643289866
ENSE0000348318532980913298218
ENSE0000349875134101883410342
ENSE0000352536734157523415855
ENSE0000354128233238343324002
ENSE0000360091032850793285111
ENSE0000363446832868593287091
ENSE0000368662632838523283975
ENSE0000390773134559063457050

Expression profiles

Bgee: expression breadth ubiquitous, 247 present calls, max score 99.32.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.4819 / max 57.4924, expressed in 1232 samples.

FANTOM5 promoters (11 alternative TSS)

Promoter IDTPM avgSamples expressed
714752.1543932
714761.2880702
714690.2212103
714720.190290
714740.181077
714730.154176
714650.099135
714710.084523
714700.083039
714640.02237

Top tissues by expression

255 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
pancreatic ductal cellCL:000207999.32gold quality
ileal mucosaUBERON:000033198.21gold quality
ganglionic eminenceUBERON:000402396.01gold quality
secondary oocyteCL:000065594.75gold quality
gingival epitheliumUBERON:000194994.69gold quality
bronchial epithelial cellCL:000232894.55gold quality
esophagus squamous epitheliumUBERON:000692094.45gold quality
bronchusUBERON:000218593.47gold quality
gingivaUBERON:000182893.39gold quality
cortical plateUBERON:000534392.60gold quality
amniotic fluidUBERON:000017390.84gold quality
lower esophagus mucosaUBERON:003583490.11gold quality
jejunal mucosaUBERON:000039989.99gold quality
mucosa of transverse colonUBERON:000499189.25gold quality
colonic mucosaUBERON:000031789.23gold quality
C1 segment of cervical spinal cordUBERON:000646989.09gold quality
middle temporal gyrusUBERON:000277188.72gold quality
esophagus mucosaUBERON:000246988.48gold quality
Brodmann (1909) area 23UBERON:001355488.40gold quality
duodenumUBERON:000211488.33gold quality
mucosa of sigmoid colonUBERON:000499388.08gold quality
spinal cordUBERON:000224088.00gold quality
primary visual cortexUBERON:000243687.97gold quality
corpus callosumUBERON:000233687.39gold quality
Brodmann (1909) area 46UBERON:000648387.26gold quality
stromal cell of endometriumCL:000225587.19gold quality
right uterine tubeUBERON:000130287.17gold quality
tendon of biceps brachiiUBERON:000818886.98gold quality
spermCL:000001986.87gold quality
transverse colonUBERON:000115786.87gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-7381yes438.79
E-CURD-119yes31.77
E-ANND-3yes8.28

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

194 targeting SLC22A23, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-8485100.0077.574731
HSA-MIR-4455100.0065.481587
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-6748-5P100.0065.811057
HSA-MIR-450099.9972.722367
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-186-5P99.9970.833707
HSA-MIR-451499.9967.101870
HSA-MIR-366299.9973.825684
HSA-MIR-477599.9875.006394
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-4715-3P99.9866.03670
HSA-MIR-493-5P99.9672.472382
HSA-MIR-302E99.9670.742669

Literature-anchored findings (GeneRIF, showing 2)

  • Genetic variations in the SLC22A23 locus contribute to the susceptibility to inflammatory bowel disease in a small fraction of white patients. (PMID:24740203)
  • Circular RNA CircSLC22A23 Promotes Gastric Cancer Progression by Activating HNRNPU Expression. (PMID:38400886)

Cross-species orthologs

43 orthologs

OrganismSymbolGene ID
danio_rerioslc22a23ENSDARG00000078856
mus_musculusSlc22a23ENSMUSG00000038267
rattus_norvegicusSlc22a23ENSRNOG00000017210
drosophila_melanogasterOrctFBGN0019952
drosophila_melanogasterCG15221FBGN0030331
drosophila_melanogasterBalatFBGN0033778
drosophila_melanogasterCG5592FBGN0035645
drosophila_melanogasterCG10486FBGN0035647
drosophila_melanogasterCG14691FBGN0037829
drosophila_melanogasterCG14855FBGN0038260
drosophila_melanogasterCG14856FBGN0038261
drosophila_melanogasterCG14857FBGN0038262
drosophila_melanogasterCG12783FBGN0038448
drosophila_melanogasterCG7333FBGN0038715
drosophila_melanogasterCG7342FBGN0038716
drosophila_melanogasterCG17751FBGN0038717
drosophila_melanogasterCG17752FBGN0038718
drosophila_melanogasterCG16727FBGN0038719
drosophila_melanogasterCG6231FBGN0038720
drosophila_melanogasterCG4465FBGN0038750
drosophila_melanogasterCG4462FBGN0038752
drosophila_melanogasterCG4459FBGN0038753
drosophila_melanogasterCG6356FBGN0039178
drosophila_melanogasterCG3690FBGN0040350
drosophila_melanogasterCG31103FBGN0051103
drosophila_melanogasterCG31106FBGN0051106
drosophila_melanogasterCG31272FBGN0051272
drosophila_melanogasterCG33233FBGN0053233
drosophila_melanogasterCG33234FBGN0053234
drosophila_melanogasterOrct2FBGN0086365
drosophila_melanogasterCG42269FBGN0259164
drosophila_melanogasterCG44098FBGN0264907
caenorhabditis_elegansWBGENE00003837
caenorhabditis_elegansoct-1WBGENE00003842
caenorhabditis_elegansWBGENE00003843
caenorhabditis_elegansWBGENE00006220
caenorhabditis_elegansWBGENE00008110
caenorhabditis_elegansWBGENE00011456
caenorhabditis_elegansWBGENE00014127
caenorhabditis_elegansWBGENE00017751
caenorhabditis_elegansWBGENE00019408
caenorhabditis_elegansWBGENE00020701
caenorhabditis_elegansWBGENE00044455

Paralogs (22): SLC22A16 (ENSG00000004809), SLC22A17 (ENSG00000092096), SLC22A2 (ENSG00000112499), SLC22A7 (ENSG00000137204), SLC22A14 (ENSG00000144671), SLC22A3 (ENSG00000146477), SLC22A8 (ENSG00000149452), SLC22A9 (ENSG00000149742), SVOPL (ENSG00000157703), SLC22A15 (ENSG00000163393), SVOP (ENSG00000166111), SLC22A11 (ENSG00000168065), SLC22A13 (ENSG00000172940), SLC22A1 (ENSG00000175003), SLC22A10 (ENSG00000184999), SLC22A25 (ENSG00000196600), SLC22A4 (ENSG00000197208), SLC22A5 (ENSG00000197375), SLC22A24 (ENSG00000197658), SLC22A12 (ENSG00000197891), SLC22A6 (ENSG00000197901), SLC22A31 (ENSG00000259803)

Protein

Protein identifiers

Solute carrier family 22 member 23A1A5C7 (reviewed: A1A5C7)

All UniProt accessions (5): A1A5C7, C9IZW5, C9J4Z0, F8WBC7, H7C4T9

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family.

Isoforms (4)

UniProt IDNamesCanonical?
A1A5C7-11yes
A1A5C7-22
A1A5C7-33
A1A5C7-44

RefSeq proteins (7): NP_001273384, NP_001273385, NP_001369246, NP_001369247, NP_001369248, NP_056297, NP_068764 (=MANE)

Domains & families (InterPro)

IDNameType
IPR005828MFS_sugar_transport-likeFamily
IPR005829Sugar_transporter_CSConserved_site
IPR020846MFS_domDomain
IPR036259MFS_trans_sfHomologous_superfamily

Pfam: PF00083

UniProt features (19 total): transmembrane region 10, splice variant 3, region of interest 2, glycosylation site 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A1A5C7-F173.390.34

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 24, 279

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 200 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_DN, GGTGTGT_MIR329, IVANOVA_HEMATOPOIESIS_MATURE_CELL, RODWELL_AGING_KIDNEY_NO_BLOOD_DN, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, chr6p25, LE_EGR2_TARGETS_UP, CORRE_MULTIPLE_MYELOMA_UP, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, HOOI_ST7_TARGETS_DN, ACTTTAT_MIR1425P, GOBP_TRANSMEMBRANE_TRANSPORT, XU_GH1_AUTOCRINE_TARGETS_DN, ATGTACA_MIR493, MODULE_534

GO Biological Process (2): monoatomic ion transport (GO:0006811), transmembrane transport (GO:0055085)

GO Molecular Function (2): transmembrane transporter activity (GO:0022857), protein binding (GO:0005515)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
cellular process1
transporter activity1
transmembrane transport1
binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

826 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC22A23SLC67A1Q96BI1649
SLC22A23SLC22A25Q6T423502
SLC22A23SLC22A15Q8IZD6498
SLC22A23SLC22A14Q9Y267487
SLC22A23NUBPLQ8TB37487
SLC22A23SLC22A10Q63ZE4459
SLC22A23CHLSNQ9BRJ6449
SLC22A23SLC18B1Q6NT16448
SLC22A23PXDC1Q5TGL8445
SLC22A23SLCO3A1Q9UIG8441
SLC22A23CFAP74Q9C0B2435
SLC22A23SLC22A11Q9NSA0431
SLC22A23RPAP3Q9H6T3423
SLC22A23SLC16A9Q7RTY1418
SLC22A23SLC22A2O15244408

IntAct

19 interactions, top by confidence:

ABTypeScore
SLC22A23NOTCH2NLApsi-mi:“MI:0915”(physical association)0.670
NOTCH2NLASLC22A23psi-mi:“MI:0915”(physical association)0.670
SLC22A23KRTAP5-9psi-mi:“MI:0915”(physical association)0.560
SLC22A23KRTAP10-8psi-mi:“MI:0915”(physical association)0.560
KRTAP10-8SLC22A23psi-mi:“MI:0915”(physical association)0.560
CLEC2DTMEM120Bpsi-mi:“MI:0914”(association)0.350
LRRC55TMEM120Bpsi-mi:“MI:0914”(association)0.350
TNFRSF10CSLC22A23psi-mi:“MI:0914”(association)0.350
LGALS8SLC22A23psi-mi:“MI:0914”(association)0.350
KRTCAP3SLC22A23psi-mi:“MI:0914”(association)0.350
SLC22A23BMP4psi-mi:“MI:0914”(association)0.350
SLC22A23MVKpsi-mi:“MI:0914”(association)0.350
SLC22A23NRP1psi-mi:“MI:0914”(association)0.350

BioGRID (73): SLC22A23 (Two-hybrid), SLC22A23 (Two-hybrid), KRTAP10-8 (Two-hybrid), NOTCH2NL (Two-hybrid), SLC22A23 (Affinity Capture-MS), SLC22A23 (Affinity Capture-MS), SLC22A23 (Affinity Capture-MS), SLC22A23 (Affinity Capture-MS), BMP4 (Affinity Capture-MS), SLC22A23 (Affinity Capture-MS), SIRT2 (Affinity Capture-MS), PAXBP1 (Affinity Capture-MS), KPRP (Affinity Capture-MS), TAX1BP1 (Affinity Capture-MS), DSCC1 (Affinity Capture-MS)

ESM2 similar proteins: A1A5C7, A6H7A0, B0BMW8, B0CM95, B0KWE9, B1MTH4, B2KI79, O43688, O62772, O75147, P0CK96, P35438, P35439, P52875, P57791, Q05586, Q28D01, Q2KJ29, Q3KNV8, Q3SZQ2, Q3UHH2, Q4L208, Q4V899, Q5R1P0, Q5R890, Q5SP67, Q5ZJ75, Q7TPB4, Q86YN1, Q8BTQ0, Q8C6G8, Q8C811, Q8R4D1, Q8VDI9, Q8VE98, Q90812, Q9BWV1, Q9D9E0, Q9H6U8, Q9H7D7

Diamond homologs: A1A5C7, A6NKX4, Q3SZQ2, Q3UHH2, Q8WUG5, Q9D9E0, Q9P290, Q9QZG1, A7MBE0, C0SPB2, Q0WUU6, Q3YAW7, Q46909, Q5RC45, Q5RLM2, Q96S37, Q9Y226, A9R4E0, C5BC70, D0CCT2, D0JKF6, D0JUX5, D0ZHC6, D5B5U5, E0T2N0, P0AEY8, P0AEY9, P0AEZ0, P39386, Q28ES4, Q323U7, Q51955, Q7CP73, Q8XB84, Q8XFG0, A0A161CLJ6, A1AHP3, A7ZTR5, A8A6H2, A8ACM0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

89 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance65
Likely benign3
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

2904 predictions. Top by Δscore:

VariantEffectΔscore
6:3283971:CATCC:Cacceptor_gain1.0000
6:3283973:TCC:Tacceptor_gain1.0000
6:3283974:CCC:Cacceptor_gain1.0000
6:3283975:CCT:Cacceptor_loss1.0000
6:3283976:C:CCacceptor_gain1.0000
6:3283976:CT:Cacceptor_loss1.0000
6:3285152:C:CTacceptor_gain1.0000
6:3285152:C:Tacceptor_gain1.0000
6:3285153:A:Tacceptor_gain1.0000
6:3285156:C:CTacceptor_gain1.0000
6:3285157:A:Tacceptor_gain1.0000
6:3285160:C:CTacceptor_gain1.0000
6:3285161:G:Tacceptor_gain1.0000
6:3286857:A:ACdonor_gain1.0000
6:3286858:C:CCdonor_gain1.0000
6:3289762:A:ACdonor_gain1.0000
6:3289763:C:CCdonor_gain1.0000
6:3289763:CG:Cdonor_gain1.0000
6:3289862:CAGCT:Cacceptor_gain1.0000
6:3289865:CT:Cacceptor_gain1.0000
6:3289867:C:CCacceptor_gain1.0000
6:3298086:CTCA:Cdonor_loss1.0000
6:3298087:TCA:Tdonor_loss1.0000
6:3298088:CACCT:Cdonor_loss1.0000
6:3298090:C:CTdonor_loss1.0000
6:3298217:TC:Tacceptor_gain1.0000
6:3298218:CCT:Cacceptor_gain1.0000
6:3323833:CGA:Cdonor_gain1.0000
6:3410186:A:ACdonor_gain1.0000
6:3410187:C:CCdonor_gain1.0000

AlphaMissense

4453 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:3273276:A:GC614R0.999
6:3273371:C:TG582D0.999
6:3273382:G:CS578R0.999
6:3273382:G:TS578R0.999
6:3273384:T:GS578R0.999
6:3273399:C:GG573R0.999
6:3273399:C:TG573R0.999
6:3283852:C:AR568M0.999
6:3283864:G:TP564Q0.999
6:3283890:G:CS555R0.999
6:3283890:G:TS555R0.999
6:3283892:T:GS555R0.999
6:3283924:C:TG544D0.999
6:3283925:C:GG544R0.999
6:3287061:A:CF448L0.999
6:3287061:A:TF448L0.999
6:3287063:A:GF448L0.999
6:3298196:A:GW369R0.999
6:3298196:A:TW369R0.999
6:3323890:C:AW342C0.999
6:3323890:C:GW342C0.999
6:3415767:C:TG248E0.999
6:3415768:C:GG248R0.999
6:3415768:C:TG248R0.999
6:3415782:C:TG243D0.999
6:3415794:C:TG239E0.999
6:3415795:C:GG239R0.999
6:3415795:C:TG239R0.999
6:3273263:A:GL618P0.998
6:3273285:A:GC611R0.998

dbSNP variants (sampled 300 via entrez): RS1000017346 (6:3405481 C>A,T), RS1000058134 (6:3283963 C>G,T), RS1000087012 (6:3399056 G>A), RS1000138111 (6:3359440 C>T), RS1000138193 (6:3360524 C>T), RS1000159598 (6:3320469 C>G), RS1000166190 (6:3331022 G>A), RS1000171880 (6:3387578 G>A,T), RS1000197511 (6:3333475 G>A), RS1000202796 (6:3397753 C>G,T), RS1000203096 (6:3387873 G>A), RS1000205752 (6:3359081 C>G,T), RS1000235083 (6:3348692 C>T), RS1000249117 (6:3311083 G>T), RS1000253004 (6:3412116 A>G)

Disease associations

OMIM: gene MIM:611697 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

59 associations (top):

StudyTraitp-value
GCST000822_1Antipsychotic drug-induced QTc interval prolongation2.000000e-07
GCST000942_1Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)9.000000e-06
GCST001762_909Obesity-related traits1.000000e-06
GCST002248_8Fasting insulin (dietary factor interaction)2.000000e-06
GCST002253_10Homeostasis model assessment of insulin resistance (dietary factor interaction)2.000000e-06
GCST002821_13Survival in rectal cancer5.000000e-06
GCST004294_7Nicotine dependence4.000000e-06
GCST004302_12Primary biliary cholangitis2.000000e-07
GCST004599_40Mean platelet volume8.000000e-13
GCST004621_91Red cell distribution width5.000000e-10
GCST005141_55Cognitive ability (MTAG)2.000000e-09
GCST005142_6Cognitive ability3.000000e-06
GCST005316_633Intelligence (MTAG)1.000000e-11
GCST005784_1Bone mineral density (femoral neck) in inflammatory bowel disease1.000000e-07
GCST006269_1160General cognitive ability3.000000e-08
GCST006804_179Red cell distribution width2.000000e-08
GCST009524_105Household income (MTAG)3.000000e-08
GCST009524_255Household income (MTAG)3.000000e-11
GCST010002_46Refractive error2.000000e-20
GCST010796_1142Electrocardiogram morphology (amplitude at temporal datapoints)3.000000e-08
GCST010796_4376Electrocardiogram morphology (amplitude at temporal datapoints)6.000000e-10
GCST010796_4377Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-10
GCST010796_4378Electrocardiogram morphology (amplitude at temporal datapoints)2.000000e-09
GCST010796_4379Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-08
GCST010796_4380Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-08
GCST010796_4423Electrocardiogram morphology (amplitude at temporal datapoints)7.000000e-13
GCST010796_4424Electrocardiogram morphology (amplitude at temporal datapoints)7.000000e-11
GCST010796_4425Electrocardiogram morphology (amplitude at temporal datapoints)7.000000e-10
GCST010796_4451Electrocardiogram morphology (amplitude at temporal datapoints)5.000000e-09
GCST010796_4452Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-08

EFO canonical traits (10, from GWAS)

EFO IDTrait name
EFO:0004520ICAM-1 measurement
EFO:0008111diet measurement
EFO:0004501HOMA-IR
EFO:0000409disease free survival
EFO:0009188Red cell distribution width
EFO:0004337intelligence
EFO:0004784self reported educational attainment
EFO:0007785femoral neck bone mineral density
EFO:0009695household income
EFO:0004327electrocardiography

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Orphan or poorly characterized SLC22 family members

CTD chemical–gene interactions

49 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression4
Valproic Aciddecreases methylation, increases expression3
Particulate Matteraffects cotreatment, increases abundance, increases expression3
Phenylmercuric Acetateaffects cotreatment, increases expression2
Aflatoxin B1affects methylation, decreases methylation2
aristolochic acid Iincreases expression1
GSK-J4decreases expression1
triphenyl phosphateaffects expression1
beta-lapachonedecreases expression1
sulforaphaneincreases expression1
butyraldehydedecreases expression1
benzo(e)pyreneincreases methylation1
aflatoxin B2affects methylation1
nickel sulfateincreases expression1
S-(1,2-dichlorovinyl)cysteinedecreases reaction, increases expression1
di-n-butylphosphoric acidaffects expression1
pseudoisocyaninedecreases reaction, increases uptake1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, increases expression1
Sunitinibincreases expression1
Zoledronic Acidincreases expression1
Acetaminophendecreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects methylation1
Vehicle Emissionsincreases abundance, increases expression1
Calcitriolincreases expression1
Cisplatindecreases expression1
Coumestroldecreases expression1
Estradiolaffects cotreatment, decreases expression1

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4IZHCT116-SLC22A23-KO-c10Cancer cell lineMale
CVCL_D4J0HCT116-SLC22A23-KO-c7Cancer cell lineMale
CVCL_TL99HAP1 SLC22A23 (-) 1Cancer cell lineMale
CVCL_XS97HAP1 SLC22A23 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.